News
News releases on November 1, 2023, page 5
Every news release public companies put out on November 1, 2023 (UTC): 773 news releases, newest first. Open any release to read it.
Rani Therapeutics Announces Strategic Program Prioritization, Expansion of Manufacturing and Plans to Streamline Business Operations to S...
Rani Therapeutics Holdings, Inc. · Nov 1, 2023
Ramaco Resources, Inc. Schedules Third Quarter 2023 Earnings Release and Conference Call; Announces Participation in Upcoming Conferences
Ramaco Resources, Inc. · Nov 1, 2023
Radware Reports Third Quarter 2023 Financial Results
Radware Ltd. · Nov 1, 2023
RADCOM to Present at the 17th Annual Needham Virtual Security, Networking, & Communications Conference on Tuesday, November 14
Radcom Ltd. · Nov 1, 2023
QuinStreet Reports Results for First Quarter Fiscal 2024
QuinStreet, Inc. · Nov 1, 2023
QuidelOrtho Reports Third Quarter 2023 Financial Results
QuidelOrtho Corporation · Nov 1, 2023
QuickLogic to Report Third Quarter Fiscal Year 2023 Financial Results on Tuesday, November 14, 2023
QuickLogic Corporation · Nov 1, 2023
Quantum-Si to Participate at Two Upcoming Investor Conferences
Quantum-Si Incorporated · Nov 1, 2023
QSRs and the American Way of Dining: Creative Realities Survey Unveils Insights
Creative Realities, Inc. · Nov 1, 2023
Qorvo® Announces Fiscal 2024 Second Quarter Financial Results
Qorvo, Inc. · Nov 1, 2023
Purple Innovation and RemWave Announce Partnership
Purple Innovation, Inc. · Nov 1, 2023
PTC Announces Fourth fiscal Quarter and Full Year 2023 Results
PTC Inc. · Nov 1, 2023
Protagonist Announces Achievement of $50M Milestone Event After Third Patient is Dosed in Phase 3 Study of JNJ-2113 in Moderate-to-Severe...
Protagonist Therapeutics, Inc. · Nov 1, 2023
Processa Pharmaceuticals Announces Formation of Oncology Advisory Board with Renowned Key Opinion Leaders
Processa Pharmaceuticals, Inc. · Nov 1, 2023
PROCEPT BioRobotics® Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
PROCEPT BioRobotics Corporation · Nov 1, 2023
Principal® Announces Financial Services Leader Pablo Sprenger to Head Latin America
Principal Financial Group Inc · Nov 1, 2023
Prenetics Global Limited Announces Reverse Stock Split
Prenetics Global Limited · Nov 1, 2023
Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology
Prelude Therapeutics Incorporated · Nov 1, 2023
Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology
AbCellera Biologics Inc. · Nov 1, 2023
Prelude Announces Strategic Pipeline Progress and Updates, including its Partnership with AbCellera, and Reports Third Quarter Financial ...
Prelude Therapeutics Incorporated · Nov 1, 2023
Preformed Line Products announces third quarter 2023 financial results
Preformed Line Products Company · Nov 1, 2023
Precision BioSciences to Report Third Quarter Results on November 7, 2023
Precision BioSciences, Inc. · Nov 1, 2023
Positive Results Announced in Largest Pivotal Phase 3 Trial of a First-in-Class Oral Antibiotic to Treat Uncomplicated Gonorrhea
Innoviva, Inc. · Nov 1, 2023
Portofino Resources Expands Pre-Drilling Exploration; Receives Confirmation of Yergo Ownership; Corporate Updates
LatAm Lithium Corp · Nov 1, 2023
PolyPid to Report Third Quarter 2023 Financial Results and Operational Highlights on November 8, 2023
PolyPid Ltd. · Nov 1, 2023
POET Technologies Announces Public Offering of Common Shares and Warrants
POET Technologies Inc. · Nov 1, 2023
Plug to Announce 2023 Third Quarter Results
Plug Power, Inc. · Nov 1, 2023
Phunware Announces Wind Down of Lyte Technology’s Operations to Reinforce Core Mission
Phunware, Inc. · Nov 1, 2023
Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA® (vonoprazan) Tablets for the Treatment of Erosive GERD and Relief of Heartbur...
Phathom Pharmaceuticals, Inc. · Nov 1, 2023
Perion Continues to Deliver Strong Results with 17% Year-Over-Year Increase in Revenue and 29% Growth in Adjusted EBITDA
Perion Network Ltd · Nov 1, 2023
Pennant Acquires Northern Texas and Southern Oklahoma Hospice Provider
The Pennant Group, Inc. · Nov 1, 2023
PayPal Reports Third Quarter 2023 Results
PayPal Holdings, Inc. · Nov 1, 2023
PayPal Names Jamie Miller as Chief Financial Officer
PayPal Holdings, Inc. · Nov 1, 2023
PAVmed to Hold a Business Update Conference Call and Webcast on November 15, 2023
PAVmed Inc. · Nov 1, 2023
Pathfinder Bancorp, Inc. Announces Third Quarter 2023 Net Income of $2.2 Million
Pathfinder Bancorp, Inc. · Nov 1, 2023
ParkOhio Announces Strong Third Quarter 2023 Results
Park-Ohio Holdings Corp. · Nov 1, 2023
Pan American Energy Mobilizes Crews For Advanced Exploration Program at Big Mack Lithium Project
Pan American Energy Corp. · Nov 1, 2023
Paltalk to Host Third Quarter 2023 Earnings Results Conference Call on Tuesday, November 7, 2023 at 4: 30 p.m. ET
Intelligent Protection Management Corp. · Nov 1, 2023
Palomar Holdings, Inc. Reports Third Quarter 2023 Results
Palomar Holdings, Inc. · Nov 1, 2023
PacBio Enables Rare and Inherited Disease Research by Adding Tertiary Analysis Partners to PacBio Compatible
Pacific Biosciences of California, Inc. · Nov 1, 2023
Outlook Therapeutics® to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology (INI) Conference
Outlook Therapeutics, Inc. · Nov 1, 2023
OrthoPediatrics Corp. Launches MP+ Bar for Clubfoot
OrthoPediatrics Corp. · Nov 1, 2023
OREO brand encourages fans to celebrate the holiday season early, offering $100,000 in prizes to those who decorate starting November 1
Mondelez International, Inc. · Nov 1, 2023
Open Lending Expands Auto Lending Inclusivity with Improved Loan Decisioning Accuracy as Vehicle Costs Soar
Open Lending Corporation · Nov 1, 2023
OneSpaWorld Reports Third Quarter Fiscal 2023 Results
OneSpaWorld Holdings Limited · Nov 1, 2023
OmniAb Appoints Steve Love to its Board of Directors
OmniAb, Inc. · Nov 1, 2023
Olema Oncology to Participate in Upcoming Investor Conferences in November
Olema Pharmaceuticals, Inc. · Nov 1, 2023
Okta to Announce Third Quarter Fiscal Year 2024 Financial Results on November 29, 2023
Okta, Inc. · Nov 1, 2023
Oculis to Present a Late-Breaking Abstract at the American Academy of Ophthalmology 2023 Annual Meeting on the Positive Stage 1 Results f...
Oculis Holding AG · Nov 1, 2023
Ocular Therapeutix™ Receives FDA Agreement Under Special Protocol Assessment (SPA) for its First Pivotal Clinical Trial of OTX-TKI in Wet...
Ocular Therapeutix, Inc. · Nov 1, 2023
Nuwellis Announces Board of Directors Transition
Nuwellis, Inc. · Nov 1, 2023
Nuvalent to Participate in the BMO Virtual BioPharma Spotlight Series: Oncology Day
Nuvalent, Inc. · Nov 1, 2023
Nutex Health Chairman and CEO Tom Vo to Speak on Panel at Upcoming Danaher Summit on Diagnostics
Nutex Health Inc. · Nov 1, 2023
Nut Brand Orchard Valley Harvest Encourages Consumers to 'Say No' To No Nut November
John B. Sanfilippo & Son, Inc. · Nov 1, 2023
Nurix Therapeutics Announces Partial Clinical Hold For NX-2127 Phase 1 Trial
Nurix Therapeutics, Inc. · Nov 1, 2023
Northern Trust Pension Universe Data: Canadian Pension Plan returns retreat in Q3, pressured by restrictive monetary policy
Northern Trust Corporation · Nov 1, 2023
Nortech Welcomes Two New Board Members
Nortech Systems Incorporated · Nov 1, 2023
Nocera Appoints Yiwen Zhang and Song-Yuan Teng to the Board of Directors
Nocera, Inc. · Nov 1, 2023
NMI Holdings, Inc. Reports Record Third Quarter 2023 Financial Results
NMI Holdings Inc · Nov 1, 2023
NIH Selects ICF for $31 Million in Biomedical and Digital Modernization Work
ICF International, Inc. · Nov 1, 2023
Newmark Group Reports Third Quarter 2023 Financial Results
Newmark Group, Inc. · Nov 1, 2023
Newmark Facilitates Sale of 2.2 Million-Square-Foot Mixed-Use Corporate Campus in Dallas/Fort Worth
Newmark Group, Inc. · Nov 1, 2023
Newegg Packs November with Deals
Newegg Commerce, Inc. · Nov 1, 2023
New Data Insights Unveiled at ASN Kidney Week 2023 Point to the Impact of the Tablo® Hemodialysis System on Equitable Kidney Care
Outset Medical, Inc. · Nov 1, 2023
Newcore Gold Commissions Updated Preliminary Economic Assessment Study for Enchi Gold Project, Ghana
Newcore Gold Ltd. · Nov 1, 2023
NeuroSense Therapeutics to Participate in BIO-Europe Fall
NeuroSense Therapeutics Ltd. · Nov 1, 2023
Neumora Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
Neumora Therapeutics, Inc. · Nov 1, 2023
Nephros Hires Judy Krandel as Chief Financial Officer
Nephros, Inc. · Nov 1, 2023
Neonode to Report Third Quarter 2023 Results on November 9, 2023
Neonode Inc. · Nov 1, 2023
Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development
Nautilus Biotechnology, Inc. · Nov 1, 2023
Natural Health Trends Reports Third Quarter 2023 Financial Results
Natural Health Trends Corp. · Nov 1, 2023
Nasdaq Completes Acquisition of Adenza
Nasdaq, Inc. · Nov 1, 2023
NAPCO Security Technologies to Announce Fiscal First Quarter 2024 Results Monday, November 6, 2023
NAPCO Security Technologies, Inc. · Nov 1, 2023
Myriad Genetics Appoints Sam Raha as Chief Operating Officer
Myriad Genetics, Inc. · Nov 1, 2023
Motorsport Games to Report Third Quarter 2023 Financial Results
Motorsport Games Inc. · Nov 1, 2023
Mosaic Minerals Starts Drilling on Gaboury Nickel Project in Quebec
Mosaic Minerals Corp · Nov 1, 2023
Monopar Presents Data Showing Tumor Reduction Benefit of Camsirubicin from Ongoing Phase 1b at the 2023 Connective Tissue Oncology Societ...
Monopar Therapeutics Inc. · Nov 1, 2023
Mondelēz International Reports Q3 2023 Results
Mondelez International, Inc. · Nov 1, 2023
MKS Instruments Reports Third Quarter 2023 Financial Results
MKS Inc. · Nov 1, 2023
Middlesex Water Company Named a Corporate Governance Award Finalist
Middlesex Water Company · Nov 1, 2023
MicroVision to Announce Third Quarter 2023 Results on November 8, 2023
MicroVision, Inc. · Nov 1, 2023
MicroStrategy Announces Third Quarter 2023 Financial Results
Strategy Inc · Nov 1, 2023
MercadoLibre, Inc. Third Quarter 2023 Letter to Shareholders
MercadoLibre, Inc. · Nov 1, 2023
MercadoLibre, Inc. Reports Third Quarter 2023 Financial Results
MercadoLibre, Inc. · Nov 1, 2023
MEDIA ADVISORY: ComEd Energy Doctors are available for interviews to discuss what viewers, readers and listeners can do to lower energy b...
Exelon Corporation · Nov 1, 2023
Marimaca Copper Appoints Giancarlo Bruno Lagomarsino as Non-Executive Director
Marimaca Copper Corp. · Nov 1, 2023
Mammoth Energy Services, Inc. announces 2023 third quarter earnings release and conference call schedule
Mammoth Energy Services, Inc. · Nov 1, 2023
Lundin Gold Reports Further High-grade Intercepts From 2023 Exploration Programs
Lundin Gold Inc. · Nov 1, 2023
LSI Industries Reports Fiscal 2024 First Quarter Results and Declares Quarterly Cash Dividend
LSI Industries Inc. · Nov 1, 2023
LQR House Strengthens Its Position by Acquiring Alcohol E-Commerce Platform, Enabling Direct Sales to Consumers
LQR House Inc. · Nov 1, 2023
LPL Financial Welcomes Pathway Wealth Advisors
LPL Financial Holdings Inc. · Nov 1, 2023
LivePerson launches suite of Conversational Intelligence solutions to accelerate digital and contact center transformation
LivePerson, Inc. · Nov 1, 2023
LivaNova Reports Third-Quarter 2023 Results
LivaNova PLC · Nov 1, 2023
Lipocine to Present Clinical Data on LPCN 1148 at The Liver Meeting® 2023
Lipocine Inc. · Nov 1, 2023
Limoneira’s Joint Venture with Lewis Group of Companies Announces Additional 121 Homesite Closings with Lennar and Richmond American Homes
Limoneira Co · Nov 1, 2023
Ligand Acquires Royalty on Sanofi’s TZIELD® for $20 Million
Ligand Pharmaceuticals Incorporated · Nov 1, 2023
Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Studies of Proprietary Platform in Multibillion-Dollar GLP-1 Drug Space
Lexaria Bioscience Corp. · Nov 1, 2023
LeMaitre Q3 2023 Financial Results
LeMaitre Vascular, Inc. · Nov 1, 2023
LegalZoom Launches New Compliance Product, Solving Complexity of Finding Business Licenses to Operate Legally at Federal & Local Levels
LegalZoom.com, Inc. · Nov 1, 2023
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Revolution Medicines Stockholders Vote “FOR” Proposed Acquisition ...
Revolution Medicines, Inc. · Nov 1, 2023